See the article here: Terns Pharmaceuticals Announces Leadership Transition
See the article here: Terns Pharmaceuticals Announces Leadership Transition
Go here to see the original: Harvard Bioscience to Present at Sidoti Virtual Investor Conference on August 16, 2023
Read more from the original source: Terns Pharmaceuticals Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(C)(4)
See the rest here: Ayala Pharmaceuticals Announces Abstracts on AL102 and AL101 Accepted for Presentation at ESMO Congress 2023
More here: Aspargo Laboratories, Inc. Announces Filing of Its Investigational New Drug Application for Sildenafil Oral Spray
More: Recce Pharmaceuticals Completes First Cohort Dosing of Phase l/ll UTI Rapid Infusion Clinical Trial at Scientia Clinical Research
See the rest here: CytomX Therapeutics to Report Second Quarter 2023 Financial Results on August 8, 2023
Continued here: APNIMED to Participate in the 43rd Annual Canaccord Genuity Global Growth Conference
View original post here: Ambrx Appoints Renu Vaish, M.Sc., as Chief Regulatory Officer to Lead Regulatory Affairs
Originally posted here: Zenas BioPharma Announces Publication of Phase 2 Study of Obexelimab, an Investigational Treatment for IgG4-Related Disease (IgG4-RD), in The Lancet...
Recent Comments